Samil

Samil Pharmaceutical, established in 1947, is a South Korean company dedicated to advancing human care through its core values of sincerity, science, and sharing. Operating within the Pharmaceuticals and Healthcare industries, Samil focuses on delivering comprehensive health solutions and maintaining a strong commitment to research and development. The company's strategic vision centers on innovation and patient well-being, solidifying its position as a key player in the sector. Its operations are anchored by a commitment to ethical practices and scientific rigor, ensuring the quality and efficacy of its offerings.

The company excels in providing specialized services, including Contract Development and Manufacturing Organization (CDMO) and robust Research & Development (R&D) capabilities. Samil actively cultivates strategic collaborations with global partners to enhance its technological prowess and market reach. The organization emphasizes recruiting talented individuals who embody both compassion and intellectual curiosity, contributing to a dynamic work environment. Meet Samil's team to discover the professionals driving these initiatives. Samil operates with 500-1,000 employees and maintains a single primary location, underscoring its focused operational structure.

With a revenue of $147.5M, Samil Pharmaceutical demonstrates significant economic activity within its operational scope. The company is publicly traded under the ticker KRX: 000520.KS, indicating its presence in the financial markets. Beyond its commercial endeavors, Samil actively engages in Corporate Social Responsibility (CSR) initiatives, aiming to make a positive societal impact. This dual focus on business excellence and community contribution defines Samil's comprehensive approach to corporate citizenship and market engagement.